Eben Tessari - Net Worth and Insider Trading

Eben Tessari Net Worth

The estimated net worth of Eben Tessari is at least $3 Million dollars as of 2024-10-20. Eben Tessari is the CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 109,975 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $3 Million. Details can be seen in Eben Tessari's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eben Tessari has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eben Tessari

To

Eben Tessari Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eben Tessari owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .

Click here to see the complete history of Eben Tessari’s form 4 insider trades.

Insider Ownership Summary of Eben Tessari

Ticker Comapny Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals International PLC 2024-10-15 Chief Business Officer

Eben Tessari Latest Holdings Summary

Eben Tessari currently owns a total of 1 stock. Eben Tessari owns 109,975 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of October 15, 2024, with a value of $3 Million.

Latest Holdings of Eben Tessari

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals International PLC 2024-10-15 109,975 26.26 2,887,944

Holding Weightings of Eben Tessari


Eben Tessari Form 4 Trading Tracker

According to the SEC Form 4 filings, Eben Tessari has made a total of 3 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 17,000 shares on October 15, 2024, which brought Eben Tessari around $456,790.

Insider Trading History of Eben Tessari

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eben Tessari Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eben Tessari Ownership Network

Ownership Network List of Eben Tessari

No Data

Ownership Network Relation of Eben Tessari

Insider Network Chart

Eben Tessari Owned Company Details

What does Kiniksa Pharmaceuticals International PLC do?

Who are the key executives at Kiniksa Pharmaceuticals International PLC?

Eben Tessari is the Chief Business Officer of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Group VP & Rilonacept GM Ross Moat , Chief Medical Officer John Paolini , and Interim CFO Mark Ragosa .

Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary

Over the past 18 months, Eben Tessari made 3 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 52,000. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 363,570 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 363,570 shares. During the past 18 months, 539,163 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 539,163 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals International PLC Insider Transactions

No Available Data

Eben Tessari Mailing Address

Above is the net worth, insider trading, and ownership report for Eben Tessari. You might contact Eben Tessari via mailing address: C/o Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.

Discussions on Eben Tessari

No discussions yet.